Pfizer, BioNTech sues Poland, Hungary over Covid debts

Published On 2023-12-20 08:00 GMT   |   Update On 2023-12-20 08:00 GMT

Brussels: Pharmaceutical firms Pfizer and BioNTech are suing the governments of Poland and Hungary alleging they failed to pay for vaccines ordered during the Covid pandemic, lawyers said Tuesday.EU member countries ordered vaccines through a joint purchase scheme, and so the companies are bringing their case before the courts in Belgium, the European Commission's host country.Read...

Login or Register to read the full article

Brussels: Pharmaceutical firms Pfizer and BioNTech are suing the governments of Poland and Hungary alleging they failed to pay for vaccines ordered during the Covid pandemic, lawyers said Tuesday.

EU member countries ordered vaccines through a joint purchase scheme, and so the companies are bringing their case before the courts in Belgium, the European Commission's host country.

Read also: Pfizer-BioNTech resolves Promosome patent lawsuit over COVID vaccine

According to the law firm representing Poland, the US and German companies are demanding that Poland pay a debt of 5.6 billion zlotys, or 1.3 billion euros ($1.4 billion), plus interest. Hungary is also accused of breach of contract, but faces a smaller claim of 60 million euros for three million vaccine doses.
Pfizer confirmed the cases were under way but would not confirm the sums demanded

Read also: Pfizer concludes USD 43 billion acquisition of Seagen

Tags:    
Article Source : AFP

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News